+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Chronic Disease Management Market Size, Share & Industry Trends Analysis Report By Type (Solutions and Services), By End User (Healthcare Providers, Healthcare Payers and Others), By Disease Type, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 87 Pages
  • August 2022
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5659343
The North America Chronic Disease Management Market is expected to witness market growth of 11.0% CAGR during the forecast period (2022-2028).

Motivational interviewing and coaching are two well-known methodologies. Cost savings and better outcomes have both been linked to more patient activation and participation. But, it is still unclear whether such a scheme can genuinely lessen the financial burden of rising medical costs for those with chronic conditions.

Since some studies of disease management programmes have examined the influence on health care costs, the body of evidence is fairly thin. Few studies effectively characterize programme components in order to identify which components have an impact on costs. Whereas it is frequently believed that preventative interventions lower net health care costs, this is not always the case.

The Healthcare Navigator, a programme for the treatment of chronic diseases, was developed by the American Health Data Institute (AHDI) in 2002. The Healthcare Navigator programme is a part of an integrated approach to controlling health care utilization, and its goal is to assist client firms in lowering their health care expenditures by enhancing both self-care and the receiving of necessary preventive treatment from formal health care providers.

The US market dominated the North America Chronic Disease Management Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $2,637.9 million by 2028.The Canada market is poised to grow at a CAGR of 13.5% during (2022 - 2028). Additionally, The Mexico market is expected to witness a CAGR of 12.5% during (2022 - 2028).

Based on Type, the market is segmented into Solutions and Services. Based on End User, the market is segmented into Healthcare Providers, Healthcare Payers and Others. Based on Disease Type, the market is segmented into Diabetes, Cardiovascular diseases, Asthma, Chronic obstructive pulmonary disorders, Cancer and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Infosys Limited, ExlService Holdings, Inc., Health Catalyst, Inc., AllScripts Healthcare Solutions, Inc., Koninklijke Philips N.V., Cognizant Technology Solutions Corporation, Casenet, LLC, Cedar Gate Technologies, Clinical Excellence, Inc., and Altruista Health, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Type
  • Solutions
  • Services
By End User
  • Healthcare Providers
  • Healthcare Payers
  • Others
By Disease Type
  • Diabetes
  • Cardiovascular diseases
  • Asthma
  • Chronic obstructive pulmonary disorders
  • Cancer
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players

List of Companies Profiled in the Report:

  • Infosys Limited
  • ExlService Holdings, Inc.
  • Health Catalyst, Inc.
  • AllScripts Healthcare Solutions, Inc.
  • Koninklijke Philips N.V.
  • Cognizant Technology Solutions Corporation
  • Casenet, LLC
  • Cedar Gate Technologies
  • Clinical Excellence, Inc.
  • Altruista Health, Inc.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Chronic Disease Management Market, by Type
1.4.2 North America Chronic Disease Management Market, by End User
1.4.3 North America Chronic Disease Management Market, by Disease Type
1.4.4 North America Chronic Disease Management Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Sep - 2022, May) Leading Players
Chapter 4. North America Chronic Disease Management Market by Type
4.1 North America Solutions Market by Country
4.2 North America Services Market by Country
Chapter 5. North America Chronic Disease Management Market by End User
5.1 North America Healthcare Providers Market by Country
5.2 North America Healthcare Payers Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Chronic Disease Management Market by Disease Type
6.1 North America Diabetes Market by Country
6.2 North America Cardiovascular diseases Market by Country
6.3 North America Asthma Market by Country
6.4 North America Chronic obstructive pulmonary disorders Market by Country
6.5 North America Cancer Market by Country
6.6 North America Others Market by Country
Chapter 7. North America Chronic Disease Management Market by Country
7.1 US Chronic Disease Management Market
7.1.1 US Chronic Disease Management Market by Type
7.1.2 US Chronic Disease Management Market by End User
7.1.3 US Chronic Disease Management Market by Disease Type
7.2 Canada Chronic Disease Management Market
7.2.1 Canada Chronic Disease Management Market by Type
7.2.2 Canada Chronic Disease Management Market by End User
7.2.3 Canada Chronic Disease Management Market by Disease Type
7.3 Mexico Chronic Disease Management Market
7.3.1 Mexico Chronic Disease Management Market by Type
7.3.2 Mexico Chronic Disease Management Market by End User
7.3.3 Mexico Chronic Disease Management Market by Disease Type
7.4 Rest of North America Chronic Disease Management Market
7.4.1 Rest of North America Chronic Disease Management Market by Type
7.4.2 Rest of North America Chronic Disease Management Market by End User
7.4.3 Rest of North America Chronic Disease Management Market by Disease Type
Chapter 8. Company Profiles
8.1 Infosys Limited
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 ExlService Holdings, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.3 Health Catalyst, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 AllScripts Healthcare Solutions, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional & Segmental Analysis
8.4.4 Research & Development Expenses
8.5 Koninklijke Philips N.V.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Acquisition and Mergers:
8.5.5.4 Approvals and Trials:
8.6 Cognizant Technology Solutions Corporation
8.6.1 Company overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.6.5 SWOT Analysis
8.7 Casenet, LLC (Zyter, Inc.)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Cedar Gate Technologies
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Acquisition and Mergers:
8.9 Clinical Excellence, Inc.
8.9.1 Company Overview
8.10. Altruista Health, Inc. (HealthEdge Software, Inc.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Acquisition and Mergers:

Companies Mentioned

  • Infosys Limited
  • ExlService Holdings, Inc.
  • Health Catalyst, Inc.
  • AllScripts Healthcare Solutions, Inc.
  • Koninklijke Philips N.V.
  • Cognizant Technology Solutions Corporation
  • Casenet, LLC
  • Cedar Gate Technologies
  • Clinical Excellence, Inc.
  • Altruista Health, Inc.

Methodology

Loading
LOADING...